To see all protocols that comply with the WHO Essential Medicine List 
 This document is currently under review:

For queries relating to this document please contact feedback@eviq.org.au.

 Fluoropyrimidine overdose or overexposure:

Fluoropyrimidine overdose or overexposure may result in severe or life-threatening toxicity. An antidote is available and is highly effective if given within 96 hours.  Read more about fluoropyrimidine overdose or overexposure.

 Medicines safety update: Fluorouracil and capecitabine - DPD deficiency:

eviQ strives to ensure the information in this document is up to date. The product information for fluorouracil and capecitabine are currently being updated by the TGA to expand the existing warning and information about dihydropyrimidine dehydrogenase (DPD) deficiency. Prescribers are advised to consider a reduced starting dose where partial DPD deficiency is detected. 

This document is an evidence based summary to complement treatment protocols and includes background and rationale for specific point of care actions. It is not intended to be a comprehensive literature review of all available evidence.

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information source. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au

Send feedback for this page


Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/1744

05 Feb 2023